TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BLFS

BioLife Solutions Inc

Healthcare · Medical Instruments & Supplies

36.90$ +2.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns BioLife Solutions Inc (BLFS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.6% of the shares are freely tradable; institutional investors hold 104.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 104.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 87.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 49Mio.

Largest Shareholders

Institutions

Institutions BLFS
Name Stake (%) Shares Change (%) Date
T. Rowe Price Investment Management,Inc. 13.30 6,506,346 +19.2 03/31/2026
BlackRock Inc 12.47 6,101,765 +3.2 03/31/2026
Casdin Capital, LLC 9.51 4,655,000 -21.9 06/30/2026
Amvescap Plc. 4.80 2,348,532 -40.3 03/31/2026
Vanguard Capital Management, LLC 3.92 1,917,708 +0.0 03/31/2026
State Street Corp 3.22 1,577,076 +4.7 03/31/2026
FMR Inc 3.01 1,470,252 -5.0 03/31/2026

Funds

Funds BLFS
Name Stake (%) Shares Change (%) Date
T. Rowe Price US Small-Cap Core Equity 5.10 2,495,025 -2.6 06/30/2026
T. Rowe Price Small-Cap Stock 5.03 2,460,507 -1.4 07/31/2026
iShares Core S&P Small-Cap ETF 4.93 2,410,574 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings BLFS
Person Role Shares Value As of Type
Mathew Aby J. EVP & Chief Scientific Officer 387,833 14,311,038 $ Sep 8, 2026 direct
Wichterman Troy Chief Financial Officer 212,223 7,831,029 $ Sep 8, 2026 direct
Berard Todd Chief Marketing Officer 162,293 5,988,612 $ Sep 8, 2026 direct
Werner Sean Chief Technology Officer 47,556 1,754,816 $ Jul 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 8, 2026 Berard Todd Chief Marketing Officer Other 356 35.38 12,595
Sep 8, 2026 Mathew Aby J. EVP & Chief Scientific Officer Other 627 35.38 22,183
Sep 8, 2026 Wichterman Troy Chief Financial Officer Other 1,026 35.38 36,300
Jul 17, 2026 Werner Sean Chief Technology Officer Other 275 29.15 8,016
Jul 7, 2026 Wichterman Troy Chief Financial Officer Other 844 27.79 23,455
Jul 7, 2026 Mathew Aby J. EVP & Chief Scientific Officer Other 516 27.79 14,340
Jul 7, 2026 Berard Todd Chief Marketing Officer Other 293 27.79 8,142

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?